HomeVYT • BME
add
Vytrus Biotech SA
Previous close
€2.22
Year range
€1.78 - €2.60
Market cap
16.95M EUR
Avg Volume
951.00
P/E ratio
27.44
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.52M | 21.40% |
Operating expense | 1.13M | 8.12% |
Net income | 255.36K | 42.31% |
Net profit margin | 16.84 | 17.27% |
Earnings per share | — | — |
EBITDA | 443.07K | 41.07% |
Effective tax rate | -10.93% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.22M | 97.97% |
Total assets | 10.64M | 15.26% |
Total liabilities | 3.84M | -8.62% |
Total equity | 6.81M | — |
Shares outstanding | 7.54M | — |
Price to book | 2.47 | — |
Return on assets | 6.02% | — |
Return on capital | 7.26% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 255.36K | 42.31% |
Cash from operations | 316.45K | 348.26% |
Cash from investing | -305.15K | 15.24% |
Cash from financing | 545.60K | 11.90% |
Net change in cash | 556.90K | 181.05% |
Free cash flow | 18.74K | 115.94% |
About
Founded
2009
Website
Employees
35
